Health Care & Life Sciences » Biotechnology | Human Metabolome Technologies Inc.

Human Metabolome Technologies Inc. | Mutual Funds

Mutual Funds that own Human Metabolome Technologies Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
DIAM (Japan) Emerging Market Japanese Equity Fund
55,000
0.94%
54,501
0.57%
04/17/2017
GO UCITS ETF Solutions Plc - DAXglobal Gold Mining Fund
10,435
0.18%
10,435
0.1%
02/28/2018
Nomura Asset Nomura DIAM Japanese Equity Mother Fund
10,000
0.17%
9,500
0.16%
12/12/2016
Bayview Asset Japanese Equity Long Short Mother Fund
2,400
0.04%
-5,499
0.48%
11/27/2017

About Human Metabolome Technologies

View Profile
Address
246-2 Mizukami, Kakuganji
Tsuruoka Yamagata 997
Japan
Employees -
Website http://humanmetabolome.com
Updated 07/08/2019
Human Metabolome Technologies, Inc. engages in diagnostic technology and medical products. Its operations are carried out through the following segments: Metabolome Analysis, Biomarker, and Temporary Staffing. The Metabolome Analysis segment provides contract analysis service based on the metabolome analysis on measured samples from the clients.